Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Diasome Pharmaceuticals Inc.

Headquarters: Cleveland, OH, United States of America
Year Founded: 2004
Status: Private

BioCentury | Jun 13, 2019
Finance

Sitting it out: Why some investors are staying out of mega-series A rounds

VCs discuss why more isn’t always better when it comes to series A rounds
BioCentury | Mar 8, 2019
Targets & Mechanisms

Oral insulin innovation

How preclinical technologies could make oral insulin cheap enough to compete
BioCentury | Jul 7, 2017
Financial News

Diasome raises $30M series A

BioCentury | Jul 5, 2017
Financial News

Diasome raises $30M in series A round

BioCentury | Jun 16, 2017
Financial News

Medicxi launches $300M late-stage fund

BioCentury | Jun 16, 2017
Finance

Investing in maturity

Why Medicxi thinks Europe is ready for a late-stage crossover fund
BioCentury | Dec 8, 2008
Company News

Diasome board of directors update

Items per page:
1 - 8 of 8